| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |